Cargando…

Impact of the COVID‐19 lockdown on the arrhythmic burden of patients with implantable cardioverter‐defibrillators

BACKGROUND: In Italy, a nationwide full lockdown was declared between March and May 2020 to hinder the novel coronavirus disease 2019 (COVID‐19) pandemic. The potential individual health effects of long‐term isolation are largely unknown. The current study investigated the arrhythmic consequences of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sassone, Biagio, Virzì, Santo, Bertini, Matteo, Pasanisi, Giovanni, Manzoli, Lamberto, Myers, Jonathan, Grazzi, Giovanni, Muser, Daniele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Devices
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207039/ https://www.ncbi.nlm.nih.gov/pubmed/34022067 http://dx.doi.org/10.1111/pace.14280

Ejemplares similares

Diagnosis and management of subcutaneous implantable cardioverter‐defibrillator infections based on process mapping
por: Baddour, Larry M., et al.
Publicado: (2020)

Remote monitoring of implantable cardioverter defibrillators: Patient experiences and preferences for follow‐up
por: Timmermans, Ivy, et al.
Publicado: (2019)

Long-Term Follow-Up of Patients with Chronic Chagas Disease and Implantable Cardioverter-Defibrillator
por: Pereira, Francisca Tatiana Moreira, et al.
Publicado: (2014)

Healthcare utilization in patients with first‐time implantable cardioverter defibrillators (data from the WEBCARE study)
por: Broers, Eva R., et al.
Publicado: (2019)

Long‐term follow‐up of implantable cardioverter defibrillator patients with regard to appropriate therapy, complications, and mortality
por: Mattsson, Gustav, et al.
Publicado: (2020)

Arrhythmic triad in an implantable cardioverter‐defibrillator recipient with severe hypokalemia
por: Ciriello, Giovanni Domenico, et al.
Publicado: (2022)

Feasibility of Ultrasound-Guided Axillary Vein Puncture under Valsalva Maneuver for Diagnostic and Cardiovascular Interventional Purposes: Pacemaker and Cardioverter-Defibrillator Implantation
por: Sassone, Biagio, et al.
Publicado: (2023)

Association between implantable cardioverter-defibrillator and survival in patients awaiting heart transplantation: A meta-analysis and systematic review
por: Lin, Andrew Y., et al.
Publicado: (2021)

Implantable cardioverter-defibrillator–related procedures and associated complications in continuous flow left ventricular assist device recipients: A multicenter experience
por: Ravichandran, Ashwin, et al.
Publicado: (2021)

Renal function and the long‐term clinical outcomes of cardiac resynchronization therapy with or without defibrillation
por: Leyva, Francisco, et al.
Publicado: (2019)

Predictors of primary prevention implantable cardioverter‐defibrillator use in heart failure with reduced ejection fraction: impact of the predicted risk of sudden cardiac death and all‐cause mortality
por: Schrage, Benedikt, et al.
Publicado: (2022)

Subcutaneous implantable cardioverter-defibrillator generator removal: a multicenter analysis
por: Luker, J, et al.
Publicado: (2023)

Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience
por: Kutyifa, Valentina, et al.
Publicado: (2014)

Electrical Storm in Patients with Implantable Cardioverter-defibrillators: A Practical Overview
por: Muser, Daniele, et al.
Publicado: (2017)

Reverse remodeling and arrhythmic burden reduction in a patient with an implantable cardioverter defibrillator treated with sacubitril/valsartan: Case report
por: Corrado, Egle, et al.
Publicado: (2020)

Appropriate therapy for implantable cardioverter defibrillators used as primary versus secondary prophylaxis
por: Thuraiaiyah, J, et al.
Publicado: (2023)

Pulsed-field ablation in patients with permanent pacemaker or implantable cardioverter defibrillator: Is it safe?
por: Lennerz, C, et al.
Publicado: (2023)

Home delivery of the communicator for remote monitoring of cardiac implantable devices: A multicenter experience during the covid‐19 lockdown
por: Magnocavallo, Michele, et al.
Publicado: (2021)

A moderate 500-m treadmill walk for estimating peak oxygen uptake in men with NYHA class I-II heart failure and reduced left ventricular ejection fraction
por: Mazzoni, Gianni, et al.
Publicado: (2018)

A comparison of anti‐arrhythmic efficacy of carvedilol vs metoprolol succinate in patients with implantable cardioverter‐defibrillators
por: Ayan, Mohamed, et al.
Publicado: (2019)

Pacemaker and Defibrillator Implantation and Programming in Patients with Deep Brain Stimulation
por: Elliott, Mark, et al.
Publicado: (2019)

Detection of concealed structural heart disease by imaging in patients with apparently idiopathic premature ventricular complexes: A review of current literature
por: Sassone, Biagio, et al.
Publicado: (2019)

Outcomes after asystole events occurring during wearable defibrillator-cardioverter use
por: Liang, Jackson J, et al.
Publicado: (2018)

iPhone 12 MagSafe technology and cardiac implantable devices: Assessment of the actual risk
por: Censi, Federica, et al.
Publicado: (2022)

Effects of COVID‐19 lockdown on arrhythmias in patients with implantable cardioverter‐defibrillators in southern Italy
por: Ducceschi, Valentino, et al.
Publicado: (2022)

Effects of lockdown on physical activity and arrhythmia burden in patients with an implantable cardioverter-defibrillator: the COVID-19 Lockdown ICD-Carelink (CLIC) study
por: Ghossein, M A, et al.
Publicado: (2022)

Arrhythmic Sudden Cardiac Death and the Role of Implantable Cardioverter-Defibrillator in Patients with Cardiac Amyloidosis—A Narrative Literature Review
por: Liżewska-Springer, Aleksandra, et al.
Publicado: (2021)

Implantable cardioverter-defibrillators /
Publicado: (1994)

A quadricuspid aortic valve in an asymptomatic 40-year-old man: a case report
por: Pasanisi, Giovanni, et al.
Publicado: (2018)

Blood stream infection in patients with implantable-cardioverter defibrillator admitted to non-cardiology units: incidence, diagnostic work-up and outcome
por: Oezkartal, T, et al.
Publicado: (2023)

Subcutaneous Implantable Cardioverter Defibrillator: A Contemporary Overview
por: Guarracini, Fabrizio, et al.
Publicado: (2023)

Defibrillation Threshold Testing for Right-sided Device Implants: A Review to Inform Shared Decision-making, in Association with the British Heart Rhythm Society
por: Pope, Michael TB, et al.
Publicado: (2023)

The Italian subcutaneous implantable cardioverter-defibrillator survey: S-ICD, why not?
por: Botto, Giovanni Luca, et al.
Publicado: (2017)

The Automatic External Cardioverter-Defibrillator
por: Martínez-Rubio, Antoni, et al.
Publicado: (2004)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Rationale and design of the SafeHeart study: Development and testing of a mHealth tool for the prediction of arrhythmic events and implantable cardioverter-defibrillator therapy
por: Frodi, Diana M., et al.
Publicado: (2021)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Impact of Improvement in Walking Speed on Hospitalization and Mortality in Females with Cardiovascular Disease
por: Grazzi, Giovanni, et al.
Publicado: (2020)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
por: Pires, Luis A
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_b1o60a1h0dv46ip5fms5pu6i5h